News

Stay up to date on the latest company news:
09 October 2024

Abalos Therapeutics Appoints Gerben Moolhuizen as Chief Executive Officer

18 March 2024

Abalos selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)

18 October 2022

Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer

12 August 2022

Abalos Therapeutics---arenaviruses take on cancer

14 October 2021

Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million

05 February 2020

Abalos Therapeutics Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts

15 October 2019

Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer

Events

Want to get in touch with the Abalos Therapeutics Team? Meet us at the following events:
February 26-27, 2025

Sachs Associates 18th Annual European Life Sciences CEO Forum

Location: Zurich, Switzerland

Presentation: Oral company presentation

Presenters: Gerben Moolhuizen, CEO

Date: February 26-27, 2025

Event website

March 12-14, 2025

SITC Spring Scientific

Location: San Diego, USA

Poster Presentation: Arenavirus immunotherapy induces favorable anti-tumor immune mechanisms improving checkpoint and cell therapies

Presenter: Ulrike Köhler, Senior Scientist

Date: March 12-14, 2025

Event website

May 12-14, 2025

22nd CIMT Annual Meeting

Location: Mainz, Germany

Poster Presentation

Presenter: Maria Hønholt Christensen; Research Scientist

Date: May 12-14, 2025

Event website

May 12-14, 2025

Bio€quity Europe

Location: Bruges, Belgium

Participant: Gerben Moolhuizen, CEO

Date: May 12-14, 2025

Event website

June 16-19, 2025

BIO International Convention

Location: Boston, USA

Participant: Gerben Moolhuizen, CEO

Date: June 16-19, 2025

Event website